Primary Site >> Esophagus Cancer
Gene >> CDX2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma. PMID: 16191504 |
Ref: Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. PMID: 16618413 |
Ref: COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus. PMID: 17307036 Ref: Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. PMID: 17342311 Ref: Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. PMID: 17534889 |
Ref: CDX2 hox gene product in a rat model of esophageal cancer. PMID: 19664209 |
Ref: Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus. PMID: 20844891 |
Ref: Combined tubular adenocarcinoma and hepatoid adenocarcinoma arising in Barrett esophagus. PMID: 20952273 |
Ref: Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping. PMID: 22748473 |
Ref: Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. PMID: 23933602 |